None listed
Conditions
Interventions
Intervention1: FMHMC-001: FMHMC-001 in 3c and 30c pills dose.
The medication will be administered in doses of four globules, four times daily until the provers develop symptoms or for seven days.
Cont
Sponsors
Father Muller Homoeopathic Medical College
Eligibility
Inclusion criteria
Inclusion criteria: The Prover: • should be in a general state of good health according to the Chief Coordinator/Project Director, Principal Investigator /Proving Master and Co-investigator /Supervisor. • should agree in advance to comply with instructions for keeping a day book. The prover should observe and describe symptoms that will be experienced from taking a homeopathic medication. • should be intelligent enough to record carefully the facts, subjective and objective symptoms generated by the drug during proving. • should not engage in any elective medical treatments (such as surgery or dental procedures) for the duration of the homeopathic drug proving. • should be two months clear of any homoeopathic remedy with no significant change in last 3 weeks. • should not undergo any major life changes (moving, getting married or divorced, etc.) and continue the usual habits and patterns of daily life. • is over the age of 18 years, both male and female, competent, and should sign the informed consent.
Exclusion criteria
Exclusion criteria: The Prover: • who is suffering from any acute or chronic disease. • who is under any kind of medical treatment. • who is a hysterical or anxious person. • who is having history of allergies, food hypersensitivity etc. • who is having colour blindness. • who is having addictions- brandy, wine, alcohol, narcotics and tobacco. • who has undergone surgery in last two months. • who is on prescription medication • who had taken birth control pills in the past 6 months • who is pregnant or nursing • who fails to complete the day book as instructed. • who has participated in another clinical or proving trial during the last 6 months.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Symptoms experienced by provers will be recorded.Timepoint: Within a period of 4 months from the starting of first dose | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety parameters - including blood and urine investigations.Timepoint: Pre-screening and Post-screening (after completion of 6 weeks) | — |
Countries
India
Contacts
Public ContactDr Pravas Kumar Pal
Father Muller Homoeopathic Medical College
Outcome results
None listed